technetium tc 99m pentetate has been researched along with didanosine in 1 studies
| Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (didanosine) | Trials (didanosine) | Recent Studies (post-2010) (didanosine) |
|---|---|---|---|---|---|
| 3,336 | 275 | 394 | 2,054 | 459 | 166 |
| Protein | Taxonomy | technetium tc 99m pentetate (IC50) | didanosine (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 6.26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damle, B; Doll, W; Knupp, C; Ullah, I; Wiley, G | 1 |
1 trial(s) available for technetium tc 99m pentetate and didanosine
| Article | Year |
|---|---|
Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.
Topics: Adult; Anti-HIV Agents; Chemistry, Pharmaceutical; Cross-Over Studies; Didanosine; Half-Life; Humans; Intestinal Absorption; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Tablets, Enteric-Coated; Technetium Tc 99m Pentetate; Therapeutic Equivalency; Time Factors | 2002 |